| Table 3. Results of the cost-effectiveness analysis. | |||||||
| Effect Outcome |
Costs difference, € (95% CI) |
Effect difference (95% CI) |
ICER €/ effect gained |
Distribution on the Cost-Effectiveness plane | |||
|---|---|---|---|---|---|---|---|
| North-East | South-East | South-West | North-West | ||||
| Main Analysis | |||||||
| Pregnancy rate/ initiated cycle | -1260 (-1401; -1118) |
-0.051 (-0.132; 0.052) |
24735 | 0% | 15% | 85% | 0% |
| SA1 | |||||||
| Pregnancy rate/ embryo transfer | -1266 (-1450; -1038) |
-0.088 (-0.236; 0.140) |
14341 | 0% | 17% | 82% | 0% |
| SA2 | |||||||
| Main analysis unadjusted | -1261 (-1404; -1103) |
-0.094 (-0.197; 0.002) |
13381 | 0% | 3% | 97% | 0% |
SA1: sensitivity analysis 1, the pregnancy rate per embryo transfer as primary effect outcome (i.e., the number of cycles in which embryos were transferred into the uterus were included in the denominator). SA2: sensitivity analysis 2, main analysis not adjusted for the propensity score.